Skip to main content

Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology

  • Protocol
  • First Online:
Neuronal Cell Culture

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1078))

Abstract

The use of primary mammalian neurons derived from embryonic central nervous system tissue is limited by the fact that once terminally differentiated into mature neurons, the cells can no longer be propagated. Transformed neuronal-like cell lines can be used in vitro to overcome this limitation. However, several caveats exist when utilizing cells derived from malignant tumors. In this context, the popular SH-SY5Y neuroblastoma cell line and its use in in vitro systems is described. Originally derived from a metastatic bone tumor biopsy, SH-SY5Y (ATCC® CRL-2266™) cells are a subline of the parental line SK-N-SH (ATCC® HTB-11™). SK-N-SH were subcloned three times; first to SH-SY, then to SH-SY5, and finally to SH-SY5Y. SH-SY5Y were deposited to the ATCC® in 1970 by June L. Biedler.

Three important characteristics of SH-SY5Y cells should be considered when using these cells in in vitro studies. First, cultures include both adherent and floating cells, both types of which are viable. Few studies address the biological significance of the adherent versus floating phenotypes, but most reported studies utilize adherent populations and discard the floating cells during media changes. Second, early studies by Biedler’s group indicated that the parental differentiated SK-N-SH cells contained two morphologically distinct phenotypes: neuroblast-like cells and epithelial-like cells (Ross et al., J Nat Cancer Inst 71:741–747, 1983). These two phenotypes may correspond to the “N” and “S” types described in later studies in SH-SY5Y by Encinas et al. (J Neurochem 75:991–1003, 2000). Cells with neuroblast-like morphology are positive for tyrosine hydroxylase (TH) and dopamine-β-hydroxylase characteristic of catecholaminergic neurons, whereas the epithelial-like counterpart cells lacked these enzymatic activities (Ross et al., J Nat Cancer Inst 71:741–747, 1983). Third, SH-SY5Y cells can be differentiated to a more mature neuron-like phenotype that is characterized by neuronal markers. There are several methods to differentiate SH-SY5Y cells and are mentioned below. Retinoic acid is the most commonly used means for differentiation and will be addressed in detail.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ross RA, Spengler BA, Biedler JL (1983) Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71(4):741–747

    PubMed  CAS  Google Scholar 

  2. Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Cena V, Gallego C, Comella JX (2000) Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75(3):991–1003

    Article  PubMed  CAS  Google Scholar 

  3. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38(11 Pt 1):3751–3757

    PubMed  CAS  Google Scholar 

  4. Adem A, Mattsson ME, Nordberg A, Pahlman S (1987) Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation. Brain Res 430(2):235–242

    PubMed  CAS  Google Scholar 

  5. Pahlman S, Odelstad L, Larsson E, Grotte G, Nilsson K (1981) Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int J Cancer 28(5):583–589

    Article  PubMed  CAS  Google Scholar 

  6. Pahlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T (1984) Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 14(2):135–144

    Article  PubMed  CAS  Google Scholar 

  7. Lopes FM, Schroder R, da Frota ML Jr, Zanotto-Filho A, Muller CB, Pires AS, Meurer RT, Colpo GD, Gelain DP, Kapczinski F, Moreira JC, Fernandes Mda C, Klamt F (2010) Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res 1337:85–94. doi:10.1016/j.brainres.2010.03.102

    Article  PubMed  CAS  Google Scholar 

  8. Tosetti P, Taglietti V, Toselli M (1998) Functional changes in potassium conductances of the human neuroblastoma cell line SH-SY5Y during in vitro differentiation. J Neurophysiol 79(2):648–658

    PubMed  CAS  Google Scholar 

  9. Xie HR, Hu LS, Li GY (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson’s disease. Chin Med J 123(8):1086–1092

    PubMed  CAS  Google Scholar 

  10. Lotan R (1996) Retinoids in cancer chemoprevention. FASEB J 10(9):1031–1039

    PubMed  CAS  Google Scholar 

  11. Melino G, Thiele CJ, Knight RA, Piacentini M (1997) Retinoids and the control of growth/death decisions in human neuroblastoma cell lines. J Neurooncol 31(1–2):65–83

    Article  PubMed  CAS  Google Scholar 

  12. Cheung YT, Lau WK, Yu MS, Lai CS, Yeung SC, So KF, Chang RC (2009) Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30(1):127–135. doi:10.1016/j.neuro.2008.11.001

    Article  PubMed  CAS  Google Scholar 

  13. Lopez-Carballo G, Moreno L, Masia S, Perez P, Barettino D (2002) Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem 277(28):25297–25304. doi:10.1074/jbc.M201869200

    Article  PubMed  CAS  Google Scholar 

  14. Itano Y, Ito A, Uehara T, Nomura Y (1996) Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells: positive and negative effects of protein kinases C and A, respectively. J Neurochem 67(1):131–137

    Article  PubMed  CAS  Google Scholar 

  15. Presgraves SP, Ahmed T, Borwege S, Joyce JN (2004) Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res 5(8):579–598

    Article  PubMed  Google Scholar 

  16. Murphy NP, Ball SG, Vaughan PF (1991) Potassium- and carbachol-evoked release of [3H]noradrenaline from human neuroblastoma cells, SH-SY5Y. J Neurochem 56(5): 1810–1815

    Article  PubMed  CAS  Google Scholar 

  17. Scott IG, Akerman KE, Heikkila JE, Kaila K, Andersson LC (1986) Development of a neural phenotype in differentiating ganglion cell-derived human neuroblastoma cells. J Cell Physiol 128(2):285–292. doi:10.1002/jcp.1041280221

    Article  PubMed  CAS  Google Scholar 

  18. Frey U, Huang YY, Kandel ER (1993) Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 260(5114):1661–1664

    Article  PubMed  CAS  Google Scholar 

  19. Sanchez S, Jimenez C, Carrera AC, Diaz-Nido J, Avila J, Wandosell F (2004) A cAMP-activated pathway, including PKA and PI3K, regulates neuronal differentiation. Neurochem Int 44(4):231–242

    Article  PubMed  CAS  Google Scholar 

  20. Kume T, Kawato Y, Osakada F, Izumi Y, Katsuki H, Nakagawa T, Kaneko S, Niidome T, Takada-Takatori Y, Akaike A (2008) Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype. Neurosci Lett 443(3):199–203. doi:10.1016/j.neulet.2008.07.079

    Article  PubMed  CAS  Google Scholar 

  21. Leli U, Shea TB, Cataldo A, Hauser G, Grynspan F, Beermann ML, Liepkalns VA, Nixon RA, Parker PJ (1993) Differential expression and subcellular localization of protein kinase C alpha, beta, gamma, delta, and epsilon isoforms in SH-SY5Y neuroblastoma cells: modifications during differentiation. J Neurochem 60(1):289–298

    Article  PubMed  CAS  Google Scholar 

  22. Tieu K, Zuo DM, Yu PH (1999) Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins. J Neurosci Res 58(3):426–435

    Article  PubMed  CAS  Google Scholar 

  23. Chen J, Chattopadhyay B, Venkatakrishnan G, Ross AH (1990) Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines. Cell Growth Differ 1(2):79–85

    PubMed  CAS  Google Scholar 

  24. Simpson PB, Bacha JI, Palfreyman EL, Woollacott AJ, McKernan RM, Kerby J (2001) Retinoic acid evoked-differentiation of neuroblastoma cells predominates over growth factor stimulation: an automated image capture and quantitation approach to neuritogenesis. Anal Biochem 298(2):163–169. doi:10.1006/abio.2001.5346

    Article  PubMed  CAS  Google Scholar 

  25. Sayas CL, Moreno-Flores MT, Avila J, Wandosell F (1999) The neurite retraction induced by lysophosphatidic acid increases Alzheimer’s disease-like Tau phosphorylation. J Biol Chem 274(52):37046–37052

    Article  PubMed  CAS  Google Scholar 

  26. Sarkanen JR, Nykky J, Siikanen J, Selinummi J, Ylikomi T, Jalonen TO (2007) Cholesterol supports the retinoic acid-induced synaptic vesicle formation in differentiating human SH-SY5Y neuroblastoma cells. J Neurochem 102(6):1941–1952. doi:10.1111/j.1471-4159.2007.04676.x

    Article  PubMed  CAS  Google Scholar 

  27. Recio-Pinto E, Ishii DN (1984) Effects of insulin, insulin-like growth factor-II and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells. Brain Res 302(2):323–334

    Article  PubMed  CAS  Google Scholar 

  28. Reddy CD, Patti R, Guttapalli A, Maris JM, Yanamandra N, Rachamallu A, Sutton LN, Phillips PC, Posner GH (2006) Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastoma. J Cell Biochem 97(1):198–206. doi:10.1002/jcb.20629

    Article  PubMed  CAS  Google Scholar 

  29. Agholme L, Lindstrom T, Kagedal K, Marcusson J, Hallbeck M (2010) An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J Alzheimers Dis 20(4):1069–1082. doi:10.3233/JAD-2010-091363

    PubMed  CAS  Google Scholar 

  30. Cuende J, Moreno S, Bolanos JP, Almeida A (2008) Retinoic acid downregulates Rae1 leading to APC(Cdh1) activation and neuroblastoma SH-SY5Y differentiation. Oncogene 27(23):3339–3344. doi:10.1038/sj.onc.1210987

    Article  PubMed  CAS  Google Scholar 

  31. Arun P, Madhavarao CN, Moffett JR, Namboodiri AM (2008) Antipsychotic drugs increase N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells. J Neurochem 106(4):1669–1680. doi:10.1111/j.1471-4159.2008.05524.x

    Article  PubMed  CAS  Google Scholar 

  32. Constantinescu R, Constantinescu AT, Reichmann H, Janetzky B (2007) Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y. J Neural Transm Suppl 72:17–28

    Article  PubMed  CAS  Google Scholar 

  33. Guarnieri S, Pilla R, Morabito C, Sacchetti S, Mancinelli R, Fano G, Mariggio MA (2009) Extracellular guanosine and GTP promote expression of differentiation markers and induce S-phase cell-cycle arrest in human SH-SY5Y neuroblastoma cells. Int J Dev Neurosci 27(2):135–147. doi:10.1016/j.ijdevneu.2008.11.007

    Article  PubMed  CAS  Google Scholar 

  34. Gould J, Reeve HL, Vaughan PF, Peers C (1992) Nicotinic acetylcholine receptors in human neuroblastoma (SH-SY5Y) cells. Neurosci Lett 145(2):201–204

    Article  PubMed  CAS  Google Scholar 

  35. Lukas RJ, Norman SA, Lucero L (1993) Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol Cell Neurosci 4(1):1–12. doi:10.1006/mcne.1993.1001

    Article  PubMed  CAS  Google Scholar 

  36. Sokolova E, Matteoni C, Nistri A (2005) Desensitization of neuronal nicotinic receptors of human neuroblastoma SH-SY5Y cells during short or long exposure to nicotine. Br J Pharmacol 146(8):1087–1095. doi:10.1038/sj.bjp.0706426

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this protocol

Cite this protocol

Kovalevich, J., Langford, D. (2013). Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology. In: Amini, S., White, M. (eds) Neuronal Cell Culture. Methods in Molecular Biology, vol 1078. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-640-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-640-5_2

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-639-9

  • Online ISBN: 978-1-62703-640-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics